Gastroparesis Market Potential Growth and Analysis of Key Players Research Forecasts to 2028
                     Gastroparesis Market
Gastroparesis is a medical condition 
characterized by the disability of stomach to 
empty itself of food in the usual way. Damaged 
nerves such as vagus nerves and muscles 
associated with gastric motility may also lead to 
gastroparesis. The condition is commonly 
observed in diabetic people. Gastroparesis can 
be classified as diabetic, idiopathic, and post-
surgical on the basis of the cause. Apart from 
these, viral infections, nerve-related diseases, 
excessive narcotics and several antidepressant 
consumption, and amyloidosis may also lead to 
the onset of gastroparesis.
Gastroparesis Market
Current and future Market Scenario
 The gastroparesis market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$6,025.11 millionby 
2027; it is expected to grow at a CAGR of 4.3%from 2020 to 2027.
 The COVID-19 pandemic has disrupted supply chain of over-the-counter (OTC) and prescription drugs, and this is likely to 
limit the market growth in the next few quarters.
 The emphasis of health care providers and medical industries on COVID-19 has led to the lowered focus on the diagnosis 
and treatment for gastroparesis, which is limiting the market growth to a certain extent.
 Apart from these, viral infections, nerve-related diseases, excessive narcotics and several antidepressant consumption, 
and amyloidosis may also lead to the onset of gastroparesis.
Key Findings
 The key findings and recommendations highlight crucial progressive industry trends in the global gastroparesis market, 
thereby allowing players across the value chain to develop effective long-term strategies.
 Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in 
the gastroparesis market.
 Highlights key business priorities in order to assist companies to realign their business strategies.
Market Insights
Increasing Geriatric Population Accelerating Demand for Gastroparesis Treatment Modalities
Gastric emptying is associated with the coordination among the motor activity of proximal stomach, distal stomach, and 
duodenum. These internal organs are controlled by the feedback mechanism from neural signals generated through the 
interaction between nutrients and small intestine. Aging leads to diminished homeostatic regulations of physiologic 
functions, along with the slowing of gastric emptying. Moreover, it influences motor and sensory functions. In addition, 
geriatric population is highly vulnerable to gastroparesis due to factors such as the poor oral medication absorption, 
inadequate appetite regulation, and postprandial glycemia.
Gastroparesis Market
Market Segments
By Type By Drug Class Type
By Distribution Channel
Idiopathic Prokinetic Agents
Hospital Pharmacies
Diabetic Botulinum Toxin Injections Retail Pharmacies
Post-surgical Antiemetic Agents Others 
Others
Gastroparesis Market
Dominating Segments
 According to the 2019 revision of World Population Prospects, 1 in 6 people would be aged more than 65 by 
2050, with an increase from 1 in 11 in 2019. Furthermore, according to the same study, one in four people in 
Europe and North America is projected to be aged over 65 by 2050. 
 The number of people with age more than 80 would reach 426 million by 2050 from 143 million in 2019. 
Thus, the continuous increase in aging population, coupled with the rise in issues associated with gastric 
emptying among these populations, drives the gastroparesis market growth.
Dominating Segments
 Type-Based Insights
On the basis of type, the gastroparesis market is segmented into idiopathic, diabetic, post-surgical, and others. The 
idiopathic segment held the largest share of the market in 2019, while the diabetic segment is estimated to register 
the highest CAGR during the forecast period.
 
 Drug Class Type-Based Insights
The gastroparesis market, based on drug class type, is segmented into prokinetic agents, antiemetic agents, and 
botulinum toxin injections. The prokinetic agents segment held the largest market share in 2019 and is estimated to 
register the highest CAGR during 2020–2027.
 Distribution Channel-Based Insights
On the basis of distribution channel, the gastroparesis market is segmented into hospital pharmacies, retail 
pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and the 
market for the same is estimated to grow at the highest CAGR from 2020 to 2027.
 Download PDF Brochure : https://www.theinsightpartners.com/sample/TIPRE00008992/ 
Dominating Segments
Gastroparesis Market – by Type
Idiopathic
Diabetic
Post-surgical
Others
Gastroparesis Market – by Drug Class Type
Prokinetic Agents
Botulinum Toxin Injections
Antiemetic Agents
Dominating Segments
Gastroparesis Market – by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Others 
Gastroparesis Market
Leading Players
Company Profiles in OTC Braces and Support Market are:
EVOKE PHARMA
Bausch Health Companies Inc. (Salix Pharmaceuticals, Ltd.)
Johnson and Johnson Services, Inc.
Allergan Plc
NEUROGASTRX, INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD
Pfizer Inc.
ANI Pharmaceuticals, Inc.
Ipca Laboratories Ltd.
Cinrx Pharma, LLC (Cindome Pharma)
  REGIONAL FRAMEWORK
REGIONAL FRAMEWORK
  Gastroparesis Market
 
 
 
Gastroparesis Market
 
        
Access Full Research Report at: 
https://www.theinsightpartners.com/reports/gastroparesis-market 
 
Thank You! 
Thank You!